(Q29616428)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

30 April 2017

0 references

Aggarwal BB

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

September 2003

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

Nature Reviews Immunology

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

30 April 2017

volume

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

30 April 2017

issue

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

30 April 2017

page(s)

745-56

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

II. Contribution to the Knowledge of Sarcoma

30 April 2017

cites work

1 reference

An endotoxin-induced serum factor that causes necrosis of tumors

31 March 2020

1 reference

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon

31 March 2020

1 reference

Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species

31 March 2020

1 reference

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

31 March 2020

1 reference

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

31 March 2020

1 reference

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

31 March 2020

1 reference

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

31 March 2020

1 reference

Identity of differentiation inducing factor and tumour necrosis factor

31 March 2020

1 reference

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

31 March 2020

1 reference

The TNF and TNF receptor superfamilies: integrating mammalian biology

31 March 2020

1 reference

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

31 March 2020

1 reference

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

31 March 2020

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

31 March 2020

1 reference

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

31 March 2020

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

31 March 2020

1 reference

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

31 March 2020

1 reference

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

31 March 2020

1 reference

VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth

31 March 2020

1 reference

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

31 March 2020

1 reference

Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase

31 March 2020

1 reference

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

31 March 2020

1 reference

A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis

31 March 2020

1 reference

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

31 March 2020

1 reference

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

31 March 2020

1 reference

The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis

31 March 2020

1 reference

Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia

31 March 2020

1 reference

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

31 March 2020

1 reference

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

31 March 2020

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

31 March 2020

1 reference

A novel domain within the 55 kd TNF receptor signals cell death

31 March 2020

1 reference

CRINKLY4: A TNFR-like receptor kinase involved in maize epidermal differentiation.

31 March 2020

1 reference

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling

31 March 2020

1 reference

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

31 March 2020

1 reference

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

31 March 2020

1 reference

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

31 March 2020

1 reference

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

31 March 2020

1 reference

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

31 March 2020

1 reference

Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages

31 March 2020

1 reference

TWEAK can induce cell death via endogenous TNF and TNF receptor 1.

31 March 2020

1 reference

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

31 March 2020

1 reference

Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-κB, Mitogen-activated Protein Kinases, and Apoptosis

31 March 2020

1 reference

Tumor necrosis factor signaling.

31 March 2020

1 reference

Signal transduction by tumor necrosis factor and its relatives

31 March 2020

1 reference

TNF-R1 signaling: a beautiful pathway

31 March 2020

1 reference

Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis

31 March 2020

1 reference

Fas ligand-induced apoptosis

31 March 2020

1 reference

The receptor for the cytotoxic ligand TRAIL

31 March 2020

1 reference

Identification and functional characterization of DR6, a novel death domain-containing TNF receptor

31 March 2020

1 reference

Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death

31 March 2020

1 reference

Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif

31 March 2020

1 reference

Structural and biochemical analysis of signal transduction by the TRAF family of adapter proteins

31 March 2020

1 reference

TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2

31 March 2020

1 reference

BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

31 March 2020

1 reference

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

31 March 2020

1 reference

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

31 March 2020

1 reference

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

31 March 2020

1 reference

Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation

31 March 2020

1 reference

Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice

31 March 2020

1 reference

Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death

31 March 2020

1 reference

The death domain kinase RIP mediates the TNF-induced NF-kappaB signal

31 March 2020

1 reference

31 March 2020

1 reference

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

31 March 2020

1 reference

Mekk3 is essential for early embryonic cardiovascular development

31 March 2020

1 reference

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

31 March 2020

1 reference

NF-kappaB at the crossroads of life and death

31 March 2020

1 reference

Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB

31 March 2020

1 reference

NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death

31 March 2020

1 reference

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

31 March 2020

1 reference

c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation

31 March 2020

1 reference

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation

31 March 2020

1 reference

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

31 March 2020

1 reference

Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy

31 March 2020

1 reference

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

31 March 2020

1 reference

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

31 March 2020

1 reference

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

31 March 2020

1 reference

The role of TNF receptor and TNF superfamily molecules in organ transplantation

31 March 2020

1 reference

BAFF AND APRIL: a tutorial on B cell survival

31 March 2020

1 reference

31 March 2020

1 reference

A role for Fas in negative selection of thymocytes in vivo

31 March 2020

1 reference

Role of defective apoptosis in type 1 diabetes and other autoimmune diseases

31 March 2020

1 reference

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

31 March 2020

1 reference

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

31 March 2020

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

31 March 2020

1 reference

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

31 March 2020

1 reference

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice

31 March 2020

1 reference

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

31 March 2020

1 reference

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

31 March 2020

1 reference

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

31 March 2020

1 reference

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

31 March 2020

1 reference

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

31 March 2020

1 reference

Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications

31 March 2020

1 reference

Inflammatory mediators and the failing heart: a translational approach

31 March 2020

1 reference

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

31 March 2020

1 reference

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

31 March 2020

1 reference

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

31 March 2020

1 reference

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

31 March 2020

1 reference

Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance

31 March 2020

1 reference

Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.

31 March 2020

1 reference

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

31 March 2020

1 reference

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

31 March 2020

1 reference

CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1).

31 March 2020

1 reference

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

31 March 2020

1 reference

Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens

31 March 2020

1 reference

Frequent Fas gene mutations in testicular germ cell tumors

31 March 2020

1 reference

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

31 March 2020

1 reference

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

31 March 2020

1 reference

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

31 March 2020

1 reference

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

454936

1037702320

0 references

454936

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12949498

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017